Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations
published in: Oncotarget
date of publication: 2015-10-16
language: English
main subject: prostate cancer, docetaxel
Cites articles 44
- 2013-01-01
- 2010-02-01
Date
Title
Article - wd:Q36562253